Post

New research · Internal Medicine
Drug metabolism and disposition: the biological fate of chemicals · 3h
StudyDrug metabolism and disposition: the biological fate of chemicals · 2026

A 3-step static mechanistic modeling approach to predicting transporter- and enzyme-mediated interaction signals of direct oral anticoagulants.

Mostafa Ben Ahmed, Anne M Filppula, Aleksi Tornio
Read paper
Internal MedicineStudy

Modeling predicted 144 potential drug interactions with direct oral anticoagulants.

A 3-step static mechanistic modeling approach to predicting transporter- and enzyme-mediated interaction signals of direct oral anticoagulants.

Mostafa Ben Ahmed … Aleksi Tornio
Drug metabolism and disposition: the biological fate of chemicals · 2026
Background

Direct oral anticoagulants (direct oral anticoagulants) are susceptible to drug-drug interactions involving both transport and metabolism.

Methods

In this study, we examined potential interactions of select precipitants with apixaban, dabigatran, edoxaban, and rivaroxaban using a 3-step static mechanistic combinatorial modeling approach.

Results
144
reveals 47 drugs that could raise or lower anticoagulant blood levels
More results

In this approach, we (1) calculated apparent estimates of the fractions of efflux transport (f e ) of the 4 direct oral anticoagulants by the intestinal breast cancer resistance protein and intestinal permeability glycoprotein (P-gp), (2) validated our estimates, and (3) used them to simulate unstudied drug interactions with the anticoagulants.

More results

We estimated P-gp and breast cancer resistance protein transport to play a similar role in the interactions of apixaban and rivaroxaban (f e_P-gp = 0.21, f e_breast cancer resistance protein = 0.13).

“
Conclusion

Using our validated model, we predicted 144 drug-drug interaction signals with potential clinical significance.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
0.8%
an oversedation event needing naloxone reversal was rare
Randomized Trial
t = -4.35
intervention caregivers asked more questions than controls
Cohort Study
67.8%
one-year survival was far worse than the intermediate-risk group's, roughly one in three died
Review
50-100%
rheumatoid arthritis raises blood clot risk well above the general population
Cross-sectional
SIR 9.93
risk climbs sharply when relatives cluster and clotting starts young
Study
82.5%
guideline-recommended anticoagulation reached most hospitalized af patients after screening
Study
7.74
Average knowledge score rose from 5.24 to 7.74 after the education intervention
Cohort Study
34.4%
just over a third stayed safely anticoagulated, most were not